Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles

Lee T.-HMING-YIH WUHSIN-FU CHENSHEE-UAN CHENHONG-NERNG HOYU-SHIH YANG2020-02-062020-02-0620060015-0282https://scholars.lib.ntu.edu.tw/handle/123456789/454511The patients undertaking a single-dose protocol for GnRH antagonist were associated with elevated serum and follicular levels of nitric oxide (NO) and decreased embryo quality scores compared with those who underwent the long protocol for GnRH agonist. The relatively poor embryo quality may be NO related instead of Fas related. ? 2006 American Society for Reproductive Medicine.[SDGs]SDG3cetrorelix; gonadorelin antagonist; nitric oxide; apoptosis; article; embryo development; enzyme linked immunosorbent assay; fertilization in vitro; nonhuman; priority journal; quality control; Dose-Response Relationship, Drug; Embryo; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Nitric Oxide; Ovarian FollicleAssociation of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cyclesjournal article10.1016/j.fertnstert.2006.02.1212-s2.0-33749239610